News in Brief
Social Sciences - Aug 5
Opinion: Is Alexander Lukashenko trying out the 'madman' theory of foreign policy?
Opinion: Is Alexander Lukashenko trying out the 'madman' theory of foreign policy?
Health - Aug 5
Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Environment - Aug 4
New satellite data reveal increasing proportion of world's population exposed to floods
New satellite data reveal increasing proportion of world's population exposed to floods
Art - Aug 3
Bridging the gap between science and art: Fermilab's artists-in-residence program hits seventh year
Bridging the gap between science and art: Fermilab's artists-in-residence program hits seventh year
science wire
« BACK
Pharmacology - Health - 22.04.2021
Health - Pharmacology - 21.04.2021
Pharmacology - Health - 20.04.2021
Pharmacology - Social Sciences - 19.04.2021
Health - Pharmacology - 16.04.2021
Pharmacology - Health - 16.04.2021
Health - Pharmacology - 15.04.2021
Pharmacology - Health - 15.04.2021
Health - Pharmacology - 15.04.2021
Health - Pharmacology - 14.04.2021
Health - Pharmacology - 14.04.2021
Health - Pharmacology - 13.04.2021
Pharmacology - Health - 13.04.2021
Health - Pharmacology - 13.04.2021 
Newly launched British biotech company pioneers ground-breaking potential treatments for COVID-19
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for coronavirus.
Health - Pharmacology - 13.04.2021
Pharmacology - Health - 13.04.2021
Health - Pharmacology - 12.04.2021
Health - Pharmacology - 12.04.2021 
Weather forecasts that predict meningitis outbreaks
Scientists are using weather forecasts to predict the location and scale of impending meningitis outbreaks in sub-Saharan Africa. It is part of an early-warning system being piloted with the aim of giving health agencies more time to activate emergency response plans.
Pharmacology - 09.04.2021
Health - Pharmacology - 07.04.2021
Health - Pharmacology - 07.04.2021
Health - Pharmacology - 07.04.2021
Health - Pharmacology - 02.04.2021
Health - Pharmacology - 02.04.2021
Health - Pharmacology - 01.04.2021
Health - Pharmacology - 01.04.2021
Pharmacology - Politics - 31.03.2021
Health - Pharmacology - 31.03.2021
Pharmacology - Health - 30.03.2021
Health - Pharmacology - 30.03.2021
Health - Pharmacology - 30.03.2021
Pharmacology - Health - 30.03.2021
Health - Pharmacology - 30.03.2021
Health - Pharmacology - 30.03.2021 
New therapeutic approach for bile duct cancer
MHH research team investigates molecular biomarkers for individualised tumour therapy. Status: 30 March 2021 Intrahepatic cholangiocarcinoma (ICC) develops within the liver. With one to two cases per 100,000 inhabitants in Germany, ICC is one of the rare diseases overall, but it is the second most common liver cancer.
Career - Pharmacology - 30.03.2021
Health - Pharmacology - 30.03.2021
Pharmacology - Health - 29.03.2021
Health - Pharmacology - 29.03.2021
Pharmacology - Health - 29.03.2021
Pharmacology - Economics / Business - 28.03.2021
Health - Pharmacology - 26.03.2021
Health - Pharmacology - 25.03.2021
Health - Pharmacology - 25.03.2021 
New partnership enables access to state-of-the-art radiotherapy machine in Oxford | University of Oxford
The new ViewRay MRIdian machine is the first of its kind in the UK and will help to improve challenging cancer treatment through faster, tailored radiotherapy.
Pharmacology - Health - 25.03.2021
Health - Pharmacology - 25.03.2021
Health - Pharmacology - 25.03.2021 
Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
Health - Pharmacology - 25.03.2021 
Immunotherapy is less efficient in non-viral liver cancer
Researchers of the UB and Clínic-IDIBAPS, together with researchers from the German Cancer Research Center in Heidelberg, lead a study that shows patients with hepatocellular carcinoma (HCC) who unde
Health - Pharmacology - 25.03.2021
Health - Pharmacology - 24.03.2021 
Patients should receive COVID-19 vaccine before surgery to reduce risk of postoperative death - study
Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population - potentially helping to avoid thousands of post-operative deaths linked to the virus, according to a new study funded by the NIHR.
Health - Pharmacology - 24.03.2021
Pharmacology
Results 201 - 250 of 2541.
Clamp technology promising for future vaccine development
University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective. The vaccine candidate developed by the team last year did not progress through to Phase 2/3 clinical trials, due to cross reactivity caused by the protein fragment used to stabilise the clamp design.
University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective. The vaccine candidate developed by the team last year did not progress through to Phase 2/3 clinical trials, due to cross reactivity caused by the protein fragment used to stabilise the clamp design.
Researchers win £1.3M funding to make a portable device to detect street drug ’spice’
A portable device to detect spice is being developed at Bath. This will be the first gadget to give on-the-spot readings for the street drug.
A portable device to detect spice is being developed at Bath. This will be the first gadget to give on-the-spot readings for the street drug.
Over-80s show similar antibody responses following single vaccination with either Pfizer or AstraZeneca vaccine - but cellular responses are enhanced after AstraZeneca vaccine
People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.
People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.
Profile: How UK doctor linked rare blood-clotting to AstraZeneca Covid jab
Professor Marie Scully (UCL Cardiovascular Science) is interviewed about her about her work identifying a new rare blood clotting syndrome linked to the AstraZeneca Covid-19 vaccine & established the correct test & treatments for patients, helping save lives.
Professor Marie Scully (UCL Cardiovascular Science) is interviewed about her about her work identifying a new rare blood clotting syndrome linked to the AstraZeneca Covid-19 vaccine & established the correct test & treatments for patients, helping save lives.
COVID-19 drug screening hub at the University of Glasgow begins work
A new COVID-19 drug screening and resistance hub in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR), has begun its vital work.
A new COVID-19 drug screening and resistance hub in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR), has begun its vital work.
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for coronavirus.
Artificial Intelligence used to automate assessment of Mesothelioma
Patients receiving treatment for the "asbestos cancer", Mesothelioma, are being assessed with Artificial Intelligence (AI) as part of a prototype imaging system which could revolutionise the way people with the disease are cared for.
Patients receiving treatment for the "asbestos cancer", Mesothelioma, are being assessed with Artificial Intelligence (AI) as part of a prototype imaging system which could revolutionise the way people with the disease are cared for.
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1,779 participants.
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1,779 participants.
Scientists are using weather forecasts to predict the location and scale of impending meningitis outbreaks in sub-Saharan Africa. It is part of an early-warning system being piloted with the aim of giving health agencies more time to activate emergency response plans.
Opinion: The risks of the AstraZeneca jab are so small, yet the gains are so great
Research into the potential link between the AstraZeneca Covid-19 vaccine and blood clots is urgently needed, but the benefits of the vaccine far outweigh the risks even if a causal link is established, says Professor David Werring (UCL Queen Square Institute of Neurology).
Research into the potential link between the AstraZeneca Covid-19 vaccine and blood clots is urgently needed, but the benefits of the vaccine far outweigh the risks even if a causal link is established, says Professor David Werring (UCL Queen Square Institute of Neurology).
Cost-effective and life-saving treatment for nation’s opioid disorder epidemic
A Stanford team of decision scientists with colleagues at the VA Palo Alto Health Care System developed a mathematical model to assess the cost-effectiveness of various interventions to treat opioid use disorder.
A Stanford team of decision scientists with colleagues at the VA Palo Alto Health Care System developed a mathematical model to assess the cost-effectiveness of various interventions to treat opioid use disorder.
Experimental Therapy for Parasitic Heart Disease May Also Help Stop COVID-19
By blocking human enzyme cathepsin L, chemical inhibitor K777 reduces coronavirus' ability to infect cell lines; clinical trials are underway James McKerrow, MD, PhD, dean of the Skaggs School of Pha
By blocking human enzyme cathepsin L, chemical inhibitor K777 reduces coronavirus' ability to infect cell lines; clinical trials are underway James McKerrow, MD, PhD, dean of the Skaggs School of Pha
Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response. The research involved 100 people aged 80 to 96, who were living independently, and had received the Pfizer vaccine twice at three weeks apart.
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response. The research involved 100 people aged 80 to 96, who were living independently, and had received the Pfizer vaccine twice at three weeks apart.
How Well do COVID-19 Vaccines Work Over the Longer Term?
A clinical trial of college students, including those at UC San Diego, will try to answer that question, and whether vaccinated persons might still pose an infection risk to others COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death.
A clinical trial of college students, including those at UC San Diego, will try to answer that question, and whether vaccinated persons might still pose an infection risk to others COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death.
Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick d
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick d
Overwhelming public support for donating vaccines to low-income countries
A survey led by the University of Oxford has found that most people in high-income countries support donating some of their country's COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.
A survey led by the University of Oxford has found that most people in high-income countries support donating some of their country's COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.
UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR
MHH research team investigates molecular biomarkers for individualised tumour therapy. Status: 30 March 2021 Intrahepatic cholangiocarcinoma (ICC) develops within the liver. With one to two cases per 100,000 inhabitants in Germany, ICC is one of the rare diseases overall, but it is the second most common liver cancer.
Uncertainty on cuts to research funding risks jeopardising UK’s position as a scientific superpower
Professor David Price, UCL Vice-Provost (Research), comments on recent uncertainty about, and cuts to, research funding: "From the rapid generation of vaccines by UK scientists to the discovery of ne
Professor David Price, UCL Vice-Provost (Research), comments on recent uncertainty about, and cuts to, research funding: "From the rapid generation of vaccines by UK scientists to the discovery of ne
FDA approves clinical trial of CRISPR treatment for sickle cell disease
In 2014, two years after her Nobel Prize-winning invention of CRISPR-Cas9 genome editing, Jennifer Doudna thought the technology was mature enough to tackle a cure for a devastating hereditary disorde
In 2014, two years after her Nobel Prize-winning invention of CRISPR-Cas9 genome editing, Jennifer Doudna thought the technology was mature enough to tackle a cure for a devastating hereditary disorde
Researchers create online resource to optimise NHS routes for housebound vaccinations
Two engineering DPhil students from the University of Oxford have created a website for GP surgeries across the UK to optimise the delivery of Covid-19 vaccinations to the UK's 1 million housebound patients.
Two engineering DPhil students from the University of Oxford have created a website for GP surgeries across the UK to optimise the delivery of Covid-19 vaccinations to the UK's 1 million housebound patients.
Big investments in vaccine capacity can help governments save lives and boost economies
Countries can accelerate vaccine supply by funding capacity buildouts-both now, and in the future Wherever they are available, COVID-19 vaccines are saving lives, lowering infection rates, and enabling economies to start recovering from the pandemic's debilitating effects.
Countries can accelerate vaccine supply by funding capacity buildouts-both now, and in the future Wherever they are available, COVID-19 vaccines are saving lives, lowering infection rates, and enabling economies to start recovering from the pandemic's debilitating effects.
Volunteers needed for study looking into whether COVID-19 and flu vaccines can be administered at the same time
Researchers at the Bristol Trials Centre (CTEU) at the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) are leading a new study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
Researchers at the Bristol Trials Centre (CTEU) at the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) are leading a new study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
Got your COVID-19 vaccine? Here’s what you should do next
UChicago Medicine's Emily Landon discusses herd immunity, possible return to pre-pandemic lifestyle As the COVID-19 vaccine rollout gains steam across the country, an increasing number of people are finding themselves with more protection from the SARS-CoV-2 virus.
UChicago Medicine's Emily Landon discusses herd immunity, possible return to pre-pandemic lifestyle As the COVID-19 vaccine rollout gains steam across the country, an increasing number of people are finding themselves with more protection from the SARS-CoV-2 virus.
The new ViewRay MRIdian machine is the first of its kind in the UK and will help to improve challenging cancer treatment through faster, tailored radiotherapy.
Carrying Naloxone Can Save Lives but Newly Abstinent Opioid Users Resist
Opioids are the main driver of fatal drug overdoses in the United States, according to the Centers for Disease Control and Prevention, resulting in 46,802 deaths in 2018, usually because the person stops breathing.
Opioids are the main driver of fatal drug overdoses in the United States, according to the Centers for Disease Control and Prevention, resulting in 46,802 deaths in 2018, usually because the person stops breathing.
Queenslanders to get their hands dirty to save lives
Queenslanders are being asked to "dig deep? in an Australian-first project, with the next "ground-breaking? medicine potentially hiding in their backyard.
Queenslanders are being asked to "dig deep? in an Australian-first project, with the next "ground-breaking? medicine potentially hiding in their backyard.
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
Researchers of the UB and Clínic-IDIBAPS, together with researchers from the German Cancer Research Center in Heidelberg, lead a study that shows patients with hepatocellular carcinoma (HCC) who unde
Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population - potentially helping to avoid thousands of post-operative deaths linked to the virus, according to a new study funded by the NIHR.
Researchers receive $6 million from NIH to explore new pancreatic cancer therapies
A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer.
A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer.
News in Brief
Social Sciences - Aug 5
Opinion: Is Alexander Lukashenko trying out the 'madman' theory of foreign policy?
Opinion: Is Alexander Lukashenko trying out the 'madman' theory of foreign policy?
Health - Aug 5
Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Environment - Aug 4
New satellite data reveal increasing proportion of world's population exposed to floods
New satellite data reveal increasing proportion of world's population exposed to floods
Art - Aug 3
Bridging the gap between science and art: Fermilab's artists-in-residence program hits seventh year
Bridging the gap between science and art: Fermilab's artists-in-residence program hits seventh year